Enhancing the chemotherapeutic efficacy of platinum prodrug nanoparticles and inhibiting cancer metastasis by targeting iron homeostasis
- 16 April 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale Horizons
- Vol. 5 (6), 999-1015
- https://doi.org/10.1039/d0nh00148a
Abstract
Iron plays important roles in tumor growth and metastasis, and iron depletion has become a new therapeutic strategy for iron overload cancers. Cisplatin is widely applied in the clinical therapy of various malignancies, but it has no inhibitory effect on cancer metastasis. In the present study, we found that the combination of cisplatin and iron chelator Dp44mT resulted in enhanced cell apoptosis as well as attenuated cell mobility and migration in vitro. Next, we developed a nano-carrier system to promote intracellular drug accumulation and reduce the side effects in cancer cells. Results showed that the as-synthesized nanoparticles (NPs) exhibited excellent antitumor efficiency when combined with Dp44mT. In breast tumor-bearing mice, the combination of the NPs and Dp44mT dramatically prevented orthotopic mammary tumor growth and inhibited metastasis via downregulation of VEGFα, MMP2 and Vimentin. In conclusion, as a versatile nano-platform for the combination of chemotherapy and iron chelators, the current design holds great potential for metastasis-inhibited cancer therapy.Funding Information
- Natural Science Foundation of Beijing Municipality (2202071)
- National Natural Science Foundation of China (51803120, 51873218)
This publication has 53 references indexed in Scilit:
- Cu(ii) immobilized on Fe3O4@APTMS-DFX nanoparticles: an efficient catalyst for the synthesis of 5-substituted 1H-tetrazoles with cytotoxic activityMedChemComm, 2017
- Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancerBiomaterials, 2017
- Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen SpeciesNano Letters, 2017
- Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanismNature Communications, 2016
- In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelatorBiomaterials, 2016
- The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in VivoInternational Journal of Molecular Sciences, 2016
- Sphingosine 1-Phosphate-Induced ICAM-1 Expression via NADPH Oxidase/ROS-Dependent NF-κB Cascade on Human Pulmonary Alveolar Epithelial CellsFrontiers in Pharmacology, 2016
- Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and DiseaseTrends in Biochemical Sciences, 2015
- Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular UptakeAdvanced Materials, 2014
- The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathwayOncotarget, 2014